Organon
↗Jersey City, USA
Organon is a global healthcare company spun off from Merck (MSD) in 2021, dedicated to improving the health of women throughout their lives. The company maintains a diverse portfolio of more than 60 medicines and products across three core pillars: Women's Health, Biosimilars, and Established Brands.
Organon is the only company of its size focused primarily on women's health, with a leadership position in contraception and fertility. It also operates a significant biosimilars business and a large franchise of established medicines in areas such as cardiovascular, respiratory, and dermatology, which provide the cash flow to fund R&D in unmet medical needs for women.
CLASSIFICATION
Company Type:Pharma
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Women's Health & Biosimilars
SIZE & FINANCIALS
Employees:10000+
Revenue:$6.4B
Founded:2021
Ownership:public
Status:operating
FUNDING
Stage:Public
Total Raised:N/A (Spinoff)
Investors:The Vanguard Group, BlackRock, State Street Global Advisors
STOCK
Exchange:NYSE
Ticker:OGN
Market Cap:$2.24B
PIPELINE
Stage:Commercial
Lead Drug Stage:Phase 3 / Regulatory Review
Modalities:Small molecule, mAb, Biosimilars, Medical Devices
Active Trials:45
Trial Phases:Phase 1: 5 | Phase 2: 12 | Phase 3: 8 | Phase 4: 20
FDA Approvals:60
EMA Approvals:55
CORPORATE STRUCTURE
Subsidiaries:Dermavant Sciences, Alydia Health, Forendo Pharma
Key Partnerships:Samsung Bioepis (Biosimilar commercialization), Eli Lilly (Emgality distribution), Shanghai Henlius Biotech (Biosimilars)
COMPETITION
Position:Leader
Competitors:Bayer, AbbVie, Pfizer, Roche, Ferring Pharmaceuticals
LEADERSHIP
Key Executives:
Joseph Morrissey - Interim CEO
Carrie S. Cox - Executive Chair
Board Members:Robert Essner, Carrie S. Cox, Shalini Sharp
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Organon. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.